Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Tilby · SciRah

Researcher profile · Semantic Scholar

M. Tilby

Share profile

M. Tilby — researcher profile on SciRah

h-index: 10
Works: 30
Citations: 505

Most-cited papers

TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease.
A. Ahmed, A. B. Griffiths, M. Tilby, B. Westley +1 more
2012American Journal of Pathology91 citations Open access
Semantic Scholar
Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogs.
M. Druce, J. Minnion, B. Field, Sejal R. Patel +6 more
2009Endocrinology89 citations
Semantic Scholar
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study
L. Lee, T. Starkey, M. Ionescu, M. Little +44 more
2022The Lancet Oncology87 citations Open access
Semantic Scholar
Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs
P. Lovat, M. Ranalli, F. Bernassola, M. Tilby +5 more
2000International Journal of Cancer70 citations Open access
Semantic Scholar
Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
Dl Roberts, K. Williams, Rl Cowen, M. Baráthová +7 more
2009British Journal of Cancer55 citations Open access
Semantic Scholar
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study
L. Lee, M. Ionescu, T. Starkey, M. Little +45 more
2022European Journal of Cancer40 citations Open access
Semantic Scholar
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
L. Lee, M. Tilby, T. Starkey, M. Ionescu +53 more
2022JAMA Oncology31 citations Open access
Semantic Scholar
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy
S. Booth, H. Curley, C. Várnai, R. Arnold +31 more
2021British Journal of Haematology31 citations Open access
Semantic Scholar
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review
Youssra Al Hajji, Harriet B. Taylor, T. Starkey, L. Lee +1 more
2022British Journal of Cancer26 citations Open access
Semantic Scholar
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer
I. Willits, L. Price, A. Parry, M. Tilby +4 more
2005British Journal of Cancer17 citations Open access
Semantic Scholar
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
T. Starkey, M. Ionescu, M. Tilby, M. Little +63 more
2023Scientific Reports14 citations Open access
Semantic Scholar
Utility of COVID-19 Screening in Cancer Patients
L. Lee, T. Hill, Oliver Topping, M. Tilby +26 more
2020Cancer Cell10 citations Open access
Semantic Scholar
Impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model - A UK weight and wellness cancer landscape analysis.
Jiawen Dong, T. Starkey, V. Cheng, J. Clark +5 more
2025Cancer Epidemiology3 citations Open access
Semantic Scholar
Ahmed ARH, Griffiths AB, Tilby MT, Westley BR, May FEB. TFF3 Is a Normal Breast Epithelial Protein and Is Associated with Differentiated Phenotype in Early Breast Cancer but Predisposes to Invasion and Metastasis in Advanced
H. Ahmed, A. B. Griffiths, M. Tilby, B. Westley +1 more
20123 citations
Semantic Scholar
Safe prescribing in cancer patients during the COVID‐19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team
Nathan Appanna, G. Patel, Emma Burke, A. Burnett +12 more
2022International Journal of Cancer2 citations Open access
Semantic Scholar
743P Real-world outcomes in patients treated with trametinib for low grade serous ovarian carcinoma
R. Shotton, X. Ren, M. Randhawa, M. Tilby +8 more
2021Annals of Oncology2 citations Open access
Semantic Scholar
Trifluridine-tipiracil for the treatment of metastatic colorectal cancer patients: UK multicentre real-world experience.
M. Tilby, C. Escola, C. Ellison, L. Narramneni +3 more
2019Annals of Oncology2 citations Open access
Semantic Scholar
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol
B. A. Fisher, A. Rowe, Chris Hodson, M. Wilkhu +20 more
2026BMJ Open1 citations Open access
Semantic Scholar
As COVID-19 cases surge despite mass vaccination, it’s time to focus on the vulnerable
M. Little, M. Fittall, H. McKenzie, M. Tilby +2 more
2021ecancermedicalscience1 citations Open access
Semantic Scholar
Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure
Lansaol Yang, M. Bryan, E. Veiga, I. Lowenhoff +41 more
2026Frontiers in Artificial Intelligence0 citations Open access
Semantic Scholar
101P Evaluating quality metrics and consistency of AI-generated patient education in colorectal cancer treatments: A cross-sectional study of five AI platforms against macmillan guidelines assessing readability, understandability, actionability, domain completion and reliability
V. K. Polisetty, S. Chitrala, M. Tilby
2026Annals of Oncology0 citations Open access
Semantic Scholar
What if Every Patient’s Immune System Could be Guided by the World’s Most Powerful Computers to Fight Cancer? The UK Cancer Vaccines AI and Supercompute Project
M. Bryan, Joseph Conway, G. Bloomfield, Aska Matsunaga +27 more
2026EMJ Innovation0 citations Open access
Semantic Scholar
Safe prescribing in cancer patients during the COVID‐19 pandemic and outcomes following restart of cancer care following SARS‐CoV‐2 infection: The COV‐SPOT initiative
Nathan Appanna, Rosie Mew, Sophie Williams, T. Starkey +25 more
2025International Journal of Cancer0 citations Open access
Semantic Scholar
UK cancer vaccine advance – Recognising and realising opportunities
Charles Craddock, P. Earwaker, M. Fittall, Elisa Fontana +26 more
2025Cambridge Prisms: Precision Medicine0 citations Open access
Semantic Scholar
The impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a markov state-transition model
Jiawen Dong, T. Starkey, V. Cheng, J. Clarke +5 more
2025Endocrine Abstracts0 citations
Semantic Scholar
P-34 The changing risk of hospitalisation, intensive care admission and death due to COVID-19 in patients with gastrointestinal cancer in the UK
M. Tilby, T. Starkey, M. Ionescu, L. Lee
2023Annals of Oncology0 citations Open access
Semantic Scholar
Association of SARS-CoV-2 Antibody Level With Risk of Infection or Hospitalization-Reply.
T. Starkey, M. Tilby, L. Lee
2023JAMA Oncology0 citations
Semantic Scholar
Abstract 804: The temporal evolution in disease phenotype of COVID-19 hospitalisation, intensive care and case fatality rates in cancer patients across the United Kingdom (UKCCP)
T. Starkey, M. Ionescu, M. Fittall, M. Tilby +13 more
2023Cancer Research0 citations
Semantic Scholar
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research
M. Fittall, Justin K. H. Liu, J. Platt, M. Ionescu +15 more
2023British Journal of Cancer0 citations Open access
Semantic Scholar
P-49 Oesophageal neuroendocrine carcinoma: Retrospective evaluation of outcomes from a UK tertiary centre
M. Tilby, R. Hejmadi, J. Thompson, I. Geh
2021Annals of Oncology0 citations Open access
Semantic Scholar
Management of stage III non-small cell lung cancer (NSCLC); outcomes from University Hospitals Birmingham NHS Foundation Trust (UHB)
R. Kussaibati, P. Bosch, R. Powell, M. Tilby +2 more
2020Lung Cancer0 citations
Semantic Scholar
Real world experience of immunotherapy in elderly patients with advanced non-small cell lung carcinoma: a retrospective study
M. Tilby, H. Ghanta, A. Jain
20200 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Lee×15
Invite
L. Lee — researcher profile on SciRah
T. Starkey×12
Invite
T. Starkey — researcher profile on SciRah
M. Little×10
Invite
M. Little — researcher profile on SciRah
Justin K. H. Liu×10
Invite
Justin K. H. Liu — researcher profile on SciRah

×10

Invite

Isabella Watts — researcher profile on SciRah

Invite

Sam Khan — researcher profile on SciRah

Invite

J. Platt — researcher profile on SciRah

Invite

M. Fittall — researcher profile on SciRah

Arvind Tripathy×7

Invite

Arvind Tripathy — researcher profile on SciRah

Invite

A. Burnett — researcher profile on SciRah

Invite

M. Ionescu — researcher profile on SciRah

Nathan Appanna×6

Invite

Nathan Appanna — researcher profile on SciRah